Does ENCORAFENIB Cause Serous retinal detachment? 297 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 297 reports of Serous retinal detachment have been filed in association with ENCORAFENIB (BRAFTOVI). This represents 3.5% of all adverse event reports for ENCORAFENIB.
297
Reports of Serous retinal detachment with ENCORAFENIB
3.5%
of all ENCORAFENIB reports
13
Deaths
56
Hospitalizations
How Dangerous Is Serous retinal detachment From ENCORAFENIB?
Of the 297 reports, 13 (4.4%) resulted in death, 56 (18.9%) required hospitalization, and 2 (0.7%) were considered life-threatening.
Is Serous retinal detachment Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENCORAFENIB. However, 297 reports have been filed with the FAERS database.
What Other Side Effects Does ENCORAFENIB Cause?
Death (1,004)
Off label use (989)
Nausea (758)
Fatigue (685)
Diarrhoea (574)
Neoplasm progression (548)
Pyrexia (539)
Product use in unapproved indication (506)
Vomiting (429)
Rash (414)
What Other Drugs Cause Serous retinal detachment?
BINIMETINIB (299)
NIVOLUMAB (67)
IPILIMUMAB (46)
DABRAFENIB (38)
COBIMETINIB (33)
TRAMETINIB DIMETHYL SULFOXIDE (33)
CETUXIMAB (32)
RANIBIZUMAB (30)
VEMURAFENIB (27)
PREDNISOLONE (23)
Which ENCORAFENIB Alternatives Have Lower Serous retinal detachment Risk?
ENCORAFENIB vs ENDOXAN
ENCORAFENIB vs ENDOXAN BAXTER
ENCORAFENIB vs ENDOXAN INJ
ENCORAFENIB vs ENDOXAN , POUDRE POUR
ENCORAFENIB vs ENFORTUMAB VEDOTIN